28/11/2025
We present a comprehensive bibliometric analysis evaluating the scientific output on Parkinson’s disease produced by the institution from 1964 to 2023.
This study incorporates 275 publications indexed in Scopus (176 clinical and 99 experimental) and examines key indicators such as research trends over time, citation patterns, collaboration networks, and journal impact factors. The results highlight:
🧠 Sustained growth in both clinical and preclinical research, with significant contributions to diagnosis, pathophysiology, and treatment.
🌐 High levels of international collaboration (59.4%), underscoring the INNN’s role as a regional leader in the neurosciences.
📉 Predominant publication in national journals with lower impact factors, signaling an important strategic opportunity to strengthen global partnerships and increase visibility through higher-impact international journals.
This analysis positions the INNN as one of the leading institutions in Latin America in neurodegenerative disease research and provides a clear roadmap to further enhance scientific impact in the coming years.
📄 Full article: Arch Neurocien (Eng). 2025;30(2):63–72
🔗 DOI: 10.24875/ANCE.M24000041